code stringlengths 4 12 | description stringlengths 2 264 | codetype stringclasses 8
values | context stringlengths 160 15.5k |
|---|---|---|---|
2007 | EPINEPHRINE .1MG/ML | CDM | 1986 China medical record followup Severity not evaluated Nestvold et al., 1974 Central Norway, Prospective identification by surgeons on duty case Survey ranked by length of PTA: None = 1, < 0.5 1988 Akershus County inclusion with neurological symptoms hr = 2, 0.5â6 hr = 3, 6â24 hr = 4, 1â2 days = 5, 3â7 (Oslo) days =... |
1995 | IMP PIST 0.6X4.5MM | CDM | 1986 China medical record followup Severity not evaluated Nestvold et al., 1974 Central Norway, Prospective identification by surgeons on duty case Survey ranked by length of PTA: None = 1, < 0.5 1988 Akershus County inclusion with neurological symptoms hr = 2, 0.5â6 hr = 3, 6â24 hr = 4, 1â2 days = 5, 3â7 (Oslo) days =... |
1993 | IMP EAR RICHARDS 0.6X3.5MM | CDM | 1986 China medical record followup Severity not evaluated Nestvold et al., 1974 Central Norway, Prospective identification by surgeons on duty case Survey ranked by length of PTA: None = 1, < 0.5 1988 Akershus County inclusion with neurological symptoms hr = 2, 0.5â6 hr = 3, 6â24 hr = 4, 1â2 days = 5, 3â7 (Oslo) days =... |
2003 | FILTER VENA CAVA FEM 7X48 SIMON NITINOL | CDM | 1986 China medical record followup Severity not evaluated Nestvold et al., 1974 Central Norway, Prospective identification by surgeons on duty case Survey ranked by length of PTA: None = 1, < 0.5 1988 Akershus County inclusion with neurological symptoms hr = 2, 0.5â6 hr = 3, 6â24 hr = 4, 1â2 days = 5, 3â7 (Oslo) days =... |
1994 | IMP PIST RICHARDS 0.6X4MM | CDM | In hospital and prehospital deaths identified severe from hospital records or death certificates Masson et al., 1996 Aquitaine, France Persons admitted to anyone of 19 public hospitals with Severe TBI by GCS of < 9 for at least 24 hrs 2003 prolonged coma determined by LOC > 24 hrs or GCS of < 9 before sedation Kleiven ... |
2007 | EPINEPHRINE .1MG/ML | CDM | In hospital and prehospital deaths identified severe from hospital records or death certificates Masson et al., 1996 Aquitaine, France Persons admitted to anyone of 19 public hospitals with Severe TBI by GCS of < 9 for at least 24 hrs 2003 prolonged coma determined by LOC > 24 hrs or GCS of < 9 before sedation Kleiven ... |
1995 | IMP PIST 0.6X4.5MM | CDM | In hospital and prehospital deaths identified severe from hospital records or death certificates Masson et al., 1996 Aquitaine, France Persons admitted to anyone of 19 public hospitals with Severe TBI by GCS of < 9 for at least 24 hrs 2003 prolonged coma determined by LOC > 24 hrs or GCS of < 9 before sedation Kleiven ... |
1993 | IMP EAR RICHARDS 0.6X3.5MM | CDM | In hospital and prehospital deaths identified severe from hospital records or death certificates Masson et al., 1996 Aquitaine, France Persons admitted to anyone of 19 public hospitals with Severe TBI by GCS of < 9 for at least 24 hrs 2003 prolonged coma determined by LOC > 24 hrs or GCS of < 9 before sedation Kleiven ... |
2003 | FILTER VENA CAVA FEM 7X48 SIMON NITINOL | CDM | In hospital and prehospital deaths identified severe from hospital records or death certificates Masson et al., 1996 Aquitaine, France Persons admitted to anyone of 19 public hospitals with Severe TBI by GCS of < 9 for at least 24 hrs 2003 prolonged coma determined by LOC > 24 hrs or GCS of < 9 before sedation Kleiven ... |
1994 | IMP PIST RICHARDS 0.6X4MM | CDM | Excludes prehospital deaths GCS: severe 9, moderate = 9â15 plus hospital 2001 Hualien County, in 2001 stay at least 48 hrs and had brain surgery or Taiwan abnormal CT scan, mild = all others Yates et al., 1997 to Royal Devon and ED database from one hospital. ICD codes used but not Based on ICD-10 but not defined 2008 ... |
2007 | EPINEPHRINE .1MG/ML | CDM | Excludes prehospital deaths GCS: severe 9, moderate = 9â15 plus hospital 2001 Hualien County, in 2001 stay at least 48 hrs and had brain surgery or Taiwan abnormal CT scan, mild = all others Yates et al., 1997 to Royal Devon and ED database from one hospital. ICD codes used but not Based on ICD-10 but not defined 2008 ... |
1995 | IMP PIST 0.6X4.5MM | CDM | Excludes prehospital deaths GCS: severe 9, moderate = 9â15 plus hospital 2001 Hualien County, in 2001 stay at least 48 hrs and had brain surgery or Taiwan abnormal CT scan, mild = all others Yates et al., 1997 to Royal Devon and ED database from one hospital. ICD codes used but not Based on ICD-10 but not defined 2008 ... |
1993 | IMP EAR RICHARDS 0.6X3.5MM | CDM | Excludes prehospital deaths GCS: severe 9, moderate = 9â15 plus hospital 2001 Hualien County, in 2001 stay at least 48 hrs and had brain surgery or Taiwan abnormal CT scan, mild = all others Yates et al., 1997 to Royal Devon and ED database from one hospital. ICD codes used but not Based on ICD-10 but not defined 2008 ... |
2003 | FILTER VENA CAVA FEM 7X48 SIMON NITINOL | CDM | Excludes prehospital deaths GCS: severe 9, moderate = 9â15 plus hospital 2001 Hualien County, in 2001 stay at least 48 hrs and had brain surgery or Taiwan abnormal CT scan, mild = all others Yates et al., 1997 to Royal Devon and ED database from one hospital. ICD codes used but not Based on ICD-10 but not defined 2008 ... |
1994 | IMP PIST RICHARDS 0.6X4MM | CDM | ICD codes used but not Based on ICD-10 but not defined 2008 2003 Exeter Hospital, stated UK Wu et al., 2008 2004 6 Providences of Hospital admitted patients with data from attending GCS: severe 9, moderate = 9â13, mild = 14, 15 Eastern China physician NOTE: AIS = Abbreviated Injury Scale, CHIRPP = Canadian Hospitals In... |
2007 | EPINEPHRINE .1MG/ML | CDM | ICD codes used but not Based on ICD-10 but not defined 2008 2003 Exeter Hospital, stated UK Wu et al., 2008 2004 6 Providences of Hospital admitted patients with data from attending GCS: severe 9, moderate = 9â13, mild = 14, 15 Eastern China physician NOTE: AIS = Abbreviated Injury Scale, CHIRPP = Canadian Hospitals In... |
1995 | IMP PIST 0.6X4.5MM | CDM | ICD codes used but not Based on ICD-10 but not defined 2008 2003 Exeter Hospital, stated UK Wu et al., 2008 2004 6 Providences of Hospital admitted patients with data from attending GCS: severe 9, moderate = 9â13, mild = 14, 15 Eastern China physician NOTE: AIS = Abbreviated Injury Scale, CHIRPP = Canadian Hospitals In... |
1993 | IMP EAR RICHARDS 0.6X3.5MM | CDM | ICD codes used but not Based on ICD-10 but not defined 2008 2003 Exeter Hospital, stated UK Wu et al., 2008 2004 6 Providences of Hospital admitted patients with data from attending GCS: severe 9, moderate = 9â13, mild = 14, 15 Eastern China physician NOTE: AIS = Abbreviated Injury Scale, CHIRPP = Canadian Hospitals In... |
2003 | FILTER VENA CAVA FEM 7X48 SIMON NITINOL | CDM | ICD codes used but not Based on ICD-10 but not defined 2008 2003 Exeter Hospital, stated UK Wu et al., 2008 2004 6 Providences of Hospital admitted patients with data from attending GCS: severe 9, moderate = 9â13, mild = 14, 15 Eastern China physician NOTE: AIS = Abbreviated Injury Scale, CHIRPP = Canadian Hospitals In... |
30233G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30243Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30233Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HAMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30243G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30233G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30233Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30243Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30243G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | When bone marrow or peripheral blood stem cell transplantation is non-covered, none of the steps are covered. (CMS Publication 100-03, Medicare National Coverage Determinations(NCD) Manual, Chapter 1, Part 2: Section 110.23). The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes national... |
30233G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30243Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30233Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HAMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30243G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30233G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30233Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30243Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30243G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | The CMS National Coverage Determination (NCD) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant, the details of which will not be repeated here. This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitation... |
30233G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30243Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30233Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HAMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30243G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30233G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30233Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30243Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30243G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | This Medical policy article describes additional locally covered indications for stem cell transplant. Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists ... |
30233G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30243Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30233Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HAMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30243G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30233G2 | TRANSFUSION OF ALLOGENEIC RELATED BONE MARROW INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30233Y2 | TRANSFUSION OF ALLOGENEIC RELATED HEMATOPOIETIC STEM CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH Reduced Intensity Medsurg | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30243Y3 | TRANSFUSION OF ALLOGENEIC UNRELATED HEMATOPOIETIC STEM CELLS INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30243G3 | TRANSFUSION OF ALLOGENEIC UNRELATED BONE MARROW INTO CENTRAL VEIN, PERCUTANEOUS APPROACH Tandem Autologous Allogeneic Unrelated Non ICU | ICD | Indications and Limitations:
Hematopoietic Progenitor Cell (HPC);Allogeneic Transplantation
The ICD-10-PCS Procedure codes are: 30233G2, 30233G3, 30233Y2, 30233Y3, 30243G2, 30243G3, 30243Y2 and 30243Y3. The NCD lists the following nationally covered indications:
- Leukemia in remission;
- Aplastic anemia;
- Severe comb... |
30243C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30233G0 | Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30243G0 | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30233Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30243Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30233C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). Allogeneic HSCT is covered only for Medicare beneficiaries with the following indications when participating in an approved prospective clinical study meeting specific criteria under the ... |
30243C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30233G0 | Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30243G0 | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30233Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30243Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30233C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | (Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2: Section 110.23). In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy ... |
30243C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
30233G0 | Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
30243G0 | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
30233Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
30243Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
30233C0 | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach Tandem Autologous Allogeneic Unrelated Non ICU | ICD | In addition to the nationally covered indications for HPC, allogenic, the following indications will be covered locally, for those jurisdictions or providers for whom this Medical Policy article applies, when medically necessary:
- Primary refractory Hodgkin's and non-Hodgkin's lymphoma; and
- Thalassemia major for pat... |
J9020 | Injection, asparaginase, not otherwise specified, 10,000 units | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9041 | INJECTION, BORTEZOMIB, 0.1 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9055 | INJECTION, CETUXIMAB, 10 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9062 | Cisplatin 50 MG injection | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9045 | INJECTION, CARBOPLATIN, 50 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9263 | oxaliplatin per 0.5 mg | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9060 | INJECTION, CISPLATIN, POWDER OR SOLUTION, 10 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
G0265 | Cryopresevation Freeze+stora | CPT | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9230 | Mechlorethamine hcl inj | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38221 | PR DIAGNOSTIC BONE MARROW BIOPSIES | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9140 | Dacarbazine 200 MG inj | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9100 | INJECTION, CYTARABINE, 100 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9010 | DOXORUBICIN HCL, 50 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38240 | Transplt allo hct/donor | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9015 | Injection, aldesleukin, per single use vial | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38210 | T-cell depletion of harvest | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38230 | PR BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9303 | panitumumab per 10 mg | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9213 | Interferon alfa-2a inj | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9380 | TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38212 | Rbc depletion of harvest | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9268 | Pentostatin injection | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
38220 | PR DIAGNOSTIC BONE MARROW ASPIRATIONS | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9130 | dacarbazine per 200 mg | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9160 | INJ DENILEUKIN DIFTITOX 300 MCG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9375 | Vincristine sulfate 2 MG inj | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9291 | Mitomycin 40 MG inj | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9000 | INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9094 | CYCLOPHOSPHAMIDE LYOPHILIZED 200 MG | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
J9265 | Paclitaxel injection | HCPCS | 2007;49(1):34-40. - National Comprehensive Cancer Network (NCCN). Central Nervous System Cancers 2014; http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed September 10, 2014. |CPT||38204||Management of recipient hematopoietic cell donor search and cell acquisition|
|38205||Blood-derived hematopoietic ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.